CRIS Current Research Information System

NANNINI, MARGHERITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.758
AS - Asia 9.460
EU - Europa 6.297
AF - Africa 635
Continente sconosciuto - Info sul continente non disponibili 541
SA - Sud America 519
OC - Oceania 19
Totale 28.229
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.545
VN - Vietnam 2.511
SG - Singapore 2.503
CN - Cina 2.329
IT - Italia 1.625
GB - Regno Unito 1.144
DE - Germania 711
HK - Hong Kong 639
SE - Svezia 609
FR - Francia 407
IN - India 395
BR - Brasile 321
RU - Federazione Russa 315
BD - Bangladesh 249
IE - Irlanda 249
CH - Svizzera 243
KR - Corea 223
NL - Olanda 201
CI - Costa d'Avorio 173
UA - Ucraina 172
FI - Finlandia 169
ZA - Sudafrica 160
JP - Giappone 148
TG - Togo 146
CA - Canada 122
EE - Estonia 96
AR - Argentina 73
AT - Austria 71
PH - Filippine 68
PL - Polonia 66
ID - Indonesia 60
SC - Seychelles 58
JO - Giordania 47
BE - Belgio 46
BG - Bulgaria 45
TH - Thailandia 44
NG - Nigeria 41
TW - Taiwan 39
MX - Messico 33
PK - Pakistan 31
IQ - Iraq 30
TR - Turchia 29
CO - Colombia 26
EC - Ecuador 24
ES - Italia 23
IR - Iran 23
GR - Grecia 21
CL - Cile 20
MY - Malesia 20
AU - Australia 18
JM - Giamaica 14
PE - Perù 14
VE - Venezuela 14
CR - Costa Rica 13
HR - Croazia 12
UY - Uruguay 12
PY - Paraguay 11
EG - Egitto 10
LT - Lituania 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 8
LB - Libano 8
TN - Tunisia 8
AO - Angola 7
DZ - Algeria 7
RO - Romania 7
SK - Slovacchia (Repubblica Slovacca) 7
NI - Nicaragua 6
ET - Etiopia 5
IL - Israele 5
MU - Mauritius 5
NO - Norvegia 5
PT - Portogallo 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
DK - Danimarca 4
GH - Ghana 4
MM - Myanmar 4
NP - Nepal 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
GT - Guatemala 3
HN - Honduras 3
KE - Kenya 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
MA - Marocco 3
PR - Porto Rico 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
BZ - Belize 2
CY - Cipro 2
GE - Georgia 2
Totale 27.653
Salva come PNG Salva come JPEG
Città #
Singapore 1.760
Ashburn 1.246
Southend 996
Fairfield 903
Chandler 740
Ho Chi Minh City 585
San Jose 585
Hong Kong 582
Hanoi 466
Hefei 457
Bologna 452
Woodbridge 441
Wilmington 415
Santa Clara 397
Houston 395
Seattle 375
Cambridge 303
Council Bluffs 292
Beijing 287
Princeton 287
Ann Arbor 270
Dublin 249
Boardman 230
Bern 219
Seoul 196
Dong Ket 195
Los Angeles 178
New York 178
Abidjan 173
Lauterbourg 164
Lomé 146
Redmond 142
Dallas 140
Helsinki 123
Nanjing 115
Tokyo 111
Westminster 111
Milan 107
Berlin 96
Padova 91
Haiphong 89
Jacksonville 85
Da Nang 83
Buffalo 79
Rome 76
São Paulo 74
Frankfurt am Main 71
Redondo Beach 68
Turin 68
Jinan 64
Munich 53
Shenyang 53
San Diego 51
Warsaw 50
Johannesburg 48
Vienna 48
Chicago 47
Amman 46
Guangzhou 46
Sofia 45
Toronto 44
Saint Petersburg 43
Bengaluru 42
Brussels 42
Jakarta 42
Shanghai 41
Nanchang 40
Zhengzhou 39
Abeokuta 38
Phoenix 37
Biên Hòa 36
Changsha 36
Falls Church 36
Florence 36
Tianjin 35
Hyderabad 34
Montreal 34
Hangzhou 33
Bremen 32
Jiaxing 32
Lappeenranta 32
London 31
Orem 31
Hebei 30
Hải Dương 30
Des Moines 29
Can Tho 28
San Francisco 28
Amsterdam 27
Dearborn 26
Denver 26
The Dalles 26
Medford 25
Thái Nguyên 25
Kuban 24
Brooklyn 23
Mülheim 23
Atlanta 22
Falkenstein 22
Yubileyny 22
Totale 17.724
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 470
Comparison of Pathological Scores for Predicting Metastasis in Pheochromocytoma and Paraganglioma: a Single-Center Experience. 338
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 284
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 278
Hippo pathway targeting in TP53-mutant Uterine Leiomyosarcoma 274
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options 265
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. 265
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 261
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 249
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 247
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. 242
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 239
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 239
Genomic Characterization of Rare Primary Cardiac Sarcoma Entities 235
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 231
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 227
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 227
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 226
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 223
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 217
The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility 217
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors 216
Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice 215
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 214
miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs 213
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 213
Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches 213
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST 213
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review). 212
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. 212
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 212
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 212
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. 211
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. 211
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 210
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 208
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. 204
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 203
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 201
Characterization of malignant gastrointestinal stromal tumors-a single center experience. 201
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile 200
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 198
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis 198
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. 198
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 197
Genomic Landscape Comparison of Cardiac versus Extra-Cardiac Angiosarcomas 196
The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST) 196
The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC) 194
Identification of an actionable mutation of kit in a case of extraskeletal myxoid chondrosarcoma 194
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 192
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 191
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report 186
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. 186
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction. 185
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 182
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 181
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 180
SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update 178
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib 177
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence A Report From the Italian Sarcoma Group 176
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild type gastrointestinal stromal tumours - Letter to the editor. 176
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. 175
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature 174
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors (GIST): A retrospective, multicenter, real-world study 174
Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients. 173
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 173
Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report 173
Microscopic margins of resection influence primary gastrointestinal stromal tumor survival. 173
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST) 173
SRF Rearrangements in Soft Tissue Tumors with Muscle Differentiation 171
Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation 171
Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression 170
Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome 170
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma 169
Exploring the Role of TERT in Thyroid Cancer: A Systematic Review 168
Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. 168
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 168
Identification of SDHA (subunit A of the succinate dehydrogenase) mutations in KIT/PDGFRA WT gastrointestinal stromal tumors (GISTs). 167
SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor 167
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 167
Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report. 166
Primary malignant pericardial tumour in Lynch syndrome 166
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 165
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 164
Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense? (Review) 164
Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis 164
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma 163
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 163
Identification of oncogenic events in gastrointestinal stromal tumors (GISTs) by combined gene expression and copy number analysis. 162
Genetic aberrations and molecular biology of cardiac sarcoma 162
Skull Metastasis From Uterine Leiomyosarcoma, a Rare Presentation for a Rare Tumor: A Case Report and Review of the Literature 161
Thoracic myopericytoma in an older adult, rare but possible: A case report 160
Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes. 160
Radiotherapy in the management of gist: state of the art and new potential scenarios 159
18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors 159
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST). 158
The follow-up issues: from the necessity to the opportunity 156
Microscopic margins of resection in gastrointestinal stromal tumor (GIST): An analysis of 122 patients 156
Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable Gastrointestinal stromal tumours treated with imatinib therapy 155
Integrative analysis of gene expression profiling and high-resolution genomic copy number in gastrointestinal stromal tumor (GIST). 154
Totale 19.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.388 0 101 110 183 233 119 63 231 125 169 592 462
2022/20233.411 365 495 178 400 190 231 98 203 542 109 267 333
2023/20241.140 124 165 57 131 98 183 63 85 35 61 62 76
2024/20253.805 197 487 338 294 552 171 302 173 77 259 213 742
2025/202610.394 1.114 875 744 714 996 543 1.264 309 2.060 855 481 439
2026/2027610 279 331 0 0 0 0 0 0 0 0 0 0
Totale 28.229